Exosome Therapy: A Novel Investigational Approach in Acute Myocardial Infarction.

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Biotechnology

Background:

• Acute myocardial infarction (AMI) is a major global health concern with limited cardiac tissue regeneration from current treatments.
• Exosomes, as cell-free vesicles, are emerging as a novel therapeutic strategy for myocardial repair.
• They contain bioactive molecules crucial for intercellular communication in healing processes.

Purpose of the Study:

• To review the therapeutic potential of exosomes for acute myocardial infarction (AMI) management.
• To explore exosome mechanisms in myocardial repair and their advantages over stem cell therapy.
• To discuss the diagnostic and prognostic applications of exosomes in AMI.

Main Methods:

• Literature review of experimental and preclinical studies on exosome-based therapy for AMI.
• Analysis of exosome characteristics, cargo, and mechanisms of action in cardiac repair.
• Evaluation of current evidence and future directions for exosome therapeutics and diagnostics in AMI.

Main Results:

• Exosomes demonstrate potential in attenuating inflammation, reducing cardiomyocyte apoptosis, enhancing angiogenesis, and promoting myocardial regeneration post-AMI.
• Exosome therapy offers advantages over stem cells, including lower immunogenicity and better stability.
• Circulating exosomes are being investigated as biomarkers for AMI detection and monitoring.

Conclusions:

• Exosome-based therapy presents a promising cell-free approach for cardiac repair following AMI.
• Engineered exosomes and targeted delivery systems may enhance therapeutic efficacy.
• Exosomes hold potential as both therapeutic agents and diagnostic biomarkers for AMI management.